TrialJAMA neurology2026

Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical Trial.

Merit Cudkowicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.